Results 71 to 80 of about 2,493 (172)
Targeting Selectins and Their Ligands in Cancer
Aberrant glycosylation is a hallmark of cancer cells with increased evidence pointing to a role in tumor progression. In particular, aberrant sialylation of glycoproteins and glycolipids have been linked to increased immune cell evasion, drug evasion ...
Alessandro eNatoni +3 more
doaj +1 more source
Metastasis, the spread of cancer cells to distant sites, remains a critical challenge in cancer treatment. This process, primarily occurring via hematogenous and lymphatic pathways, significantly contributes to cancer mortality.
Prasanna H. Megalamani +7 more
doaj +1 more source
Background Hepatocellular carcinoma (HCC) ranks as the third most common cause of cancer related death globally, representing a substantial challenge to global healthcare systems.
Zhuo Li +10 more
doaj +1 more source
Breast cancer tissue overexpresses fucosylated glycans, such as sialyl‐Lewis X/A (sLeX/A), and α‐1,3/4‐fucosyltransferases (FUTs) in relation to increased disease progression and metastasis.
Mylène A. Carrascal +10 more
doaj +1 more source
Creating a novel tobacco chassis with downregulated expression of α-1,3-fucosyltransferase 4
Tobacco (Nicotiana tabacum) is a widely used platform for producing recombinant proteins for clinical applications. However, achieving mammalian-like glycosylation modifications in plant-derived therapeutic proteins remains challenging, particularly in ...
SHAN Xuemeng +6 more
doaj +1 more source
C-6-Modified 2-F-Fucose Derivatives as Inhibitors of Fucosyltransferases. [PDF]
Liu Y, Boons GJ.
europepmc +1 more source
WrtF from <i>Rhizobium tropici</i> CIAT 899 is a GT-A fold fucosyltransferase that binds its donor nonproductively. [PDF]
Forrester TJB +3 more
europepmc +1 more source
Advances and challenges in plant N-glycoengineering: when fucosylation matters. [PDF]
Gauba K, Kunnummel V, Castilho A.
europepmc +1 more source

